Reducing synuclein accumulation improves neuronal survival after spinal cord injury

Autor: Alexandra J. van Brummen, Scott R. Allen, Susan M. L. Banks, Thomas Schrader, Frank-Gerrit Klärner, Stephanie M. Fogerson, Jennifer R. Morgan, Robin Roychaudhuri, David J. Busch, Gal Bitan
Rok vydání: 2016
Předmět:
0301 basic medicine
Morpholino
Parkinson's disease
Cell Count
Neurodegenerative
Regenerative Medicine
Morpholinos
0302 clinical medicine
2.1 Biological and endogenous factors
Psychology
Axon
Aetiology
Spinal Cord Injury
Spinal cord injury
Neurons
CLR01
Lamprey
Neurodegeneration
Lampreys
Organophosphates
medicine.anatomical_structure
Neurology
Larva
Neurological
Bridged-Ring Compounds
Physical Injury - Accidents and Adverse Effects
1.1 Normal biological development and functioning
Clinical Sciences
Chemie
Synucleins
Biology
Synaptic vesicle
Article
Synaptotagmin 1
03 medical and health sciences
Developmental Neuroscience
Underpinning research
medicine
Animals
Traumatic Head and Spine Injury
Spinal Cord Injuries
Analysis of Variance
Neurology & Neurosurgery
Animal
Neurosciences
Spinal cord
medicine.disease
Synaptotagmin
Molecular tweezer
Disease Models
Animal

030104 developmental biology
nervous system
Gene Expression Regulation
Disease Models
Synuclein
Neuroscience
030217 neurology & neurosurgery
Zdroj: Experimental neurology, vol 278
Fogerson, SM; van Brummen, AJ; Busch, DJ; Allen, SR; Roychaudhuri, R; Banks, SML; et al.(2016). Reducing synuclein accumulation improves neuronal survival after spinal cord injury. EXPERIMENTAL NEUROLOGY, 278, 105-115. doi: 10.1016/j.expneurol.2016.02.004. UCLA: Retrieved from: http://www.escholarship.org/uc/item/5hm3r4j3
DOI: 10.1016/j.expneurol.2016.02.004.
Popis: Spinal cord injury causes neuronal death, limiting subsequent regeneration and recovery. Thus, there is a need to develop strategies for improving neuronal survival after injury. Relative to our understanding of axon regeneration, comparatively little is known about the mechanisms that promote the survival of damaged neurons. To address this, we took advantage of lamprey giant reticulospinal neurons whose large size permits detailed examination of post-injury molecular responses at the level of individual, identified cells. We report here that spinal cord injury caused a select subset of giant reticulospinal neurons to accumulate synuclein, a synaptic vesicle-associated protein best known for its atypical aggregation and causal role in neurodegeneration in Parkinson's and other diseases. Post-injury synuclein accumulation took the form of punctate aggregates throughout the somata and occurred selectively in dying neurons, but not in those that survived. In contrast, another synaptic vesicle protein, synaptotagmin, did not accumulate in response to injury. We further show that the post-injury synuclein accumulation was greatly attenuated after single dose application of either the "molecular tweezer" inhibitor, CLR01, or a translation-blocking synuclein morpholino. Consequently, reduction of synuclein accumulation not only improved neuronal survival, but also increased the number of axons in the spinal cord proximal and distal to the lesion. This study is the first to reveal that reducing synuclein accumulation is a novel strategy for improving neuronal survival after spinal cord injury.
Databáze: OpenAIRE